Nifedalat 20 Sr 20 mg FC tablets
PDF Leaflet Revision Date: 31 October 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Prophylaxis of chronic stable angina pectoris and treatment of mild to moderate hypertension.
Dosage (summary)
20 mg to 40 mg twice per day.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy and breastfeeding.
Key Drug Interactions
- Grapefruit juice
- Macrolide antibiotics
- Anti-HIV protease inhibitors
- Azole antimycotics
- Fluoxetine
Contraindications
- Hypersensitivity to nifedipine
- Hepatic impairment
- Gastrointestinal obstruction
- Inflammatory bowel disease
- Cardiovascular shock
Common side effects
- Headache
- Dizziness
- Hypotension
- Peripheral edema
- Nausea
Counselling Points
- Swallow tablets whole with fluid
- Avoid grapefruit juice
- Monitor for signs of hypotension
- Report any allergic reactions
Serious warnings
- Monitor blood pressure during initiation
- Risk of heart failure in severe aortic stenosis
- May impair ability to drive
Important Disclaimer
The Nifedalat 20 Sr 20 mg FC tablets professional information leaflet below is the property of Biotech Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
